All data are based on the daily closing price as of November 20, 2026
c
Chong Kun Dang Pharmaceutical
185750.KO
46.47 USD
-0.16
-0.34%
Overview
Last close
46.47 usd
Market cap
612.29M usd
52 week high
69.35 usd
52 week low
41.76 usd
Target price
76.41 usd
Valuation
P/E
10.2789
Forward P/E
N/A
Price/Sales
0.459
Price/Book Value
0.7939
Enterprise Value
687.24M usd
EV/Revenue
0.5176
EV/EBITDA
2.1534
Key financials
Revenue TTM
1.32B usd
Gross Profit TTM
394.53M usd
EBITDA TTM
91.34M usd
Earnings per Share
4.48 usd
Dividend
0.37 usd
Total assets
1.38B usd
Net debt
N/A usd
About
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.